CVCO Cavco Industries Inc.

Cavco Industries Opens New Manufacturing Facility in the Tarheel State: Cavco Homes of North Carolina

Cavco Industries Opens New Manufacturing Facility in the Tarheel State: Cavco Homes of North Carolina

The 184,000-square-foot facility in Hamlet, North Carolina expands the company’s affordable home production capabilities

PHOENIX, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Cavco Industries, Inc. (Nasdaq: CVCO) (“Cavco” or the “Company”) today announced that the Company has opened its newest manufacturing facility in Hamlet, North Carolina. Known as “Cavco Homes of North Carolina,” the 184,000 square-foot-plant will produce homes built under the standards of the U.S. Department of Housing and Urban Development ("HUD code"). The opening comes approximately seven months after Cavco acquired the facility from Volumetric Building Companies ("VBC"), which used the facility to produce multi-family residential and commercial projects and has since moved that production to their markets in the Northeast. Cavco offered continued employment to previous VBC employees, including management staff, and additional employment opportunities are anticipated to become available with the expansion of its homebuilding production.

"At Cavco we are intensely driven to provide solutions to the pressing need for affordable homes,” said Bill Boor, President and Chief Executive Officer of Cavco. “The addition of the Hamlet facility to our growing network of 27 plants across the country is a step forward on that path. This has been a great opportunity to quickly bring new capacity online with an in-place and capable workforce. From the beginning, it was a primary objective for both VBC and Cavco that we maintain continuous employment for the people at the facility; and through careful planning and coordination, we have been able to do so. We’re very excited about the important role Hamlet will play in Cavco’s future for many years to come."

Cavco has distribution points in 48 U.S. states and in Canada, through its 45 retail stores and 27 production plants, while employing over 6,300 people. In fiscal year 2022, the Company delivered over 16,700 homes, provided over $141 million in financing to homebuyers, insured homes for over 63,600 homeowners and provided fast and efficient claims assistance to over 5,600 homeowners. Cavco is the third-largest U.S. builder of manufactured homes, with a 14% share of that market.

For more information on Cavco Industries, visit .

: .@CavcoIndustries opens new manufacturing facility in the Tarheel State: Cavco Homes of North Carolina; #manufacturedhousing; #construction; #manufacturing; #Cavco; #jobs; #hiring; #employment. Learn more at .

Media Contact

Wallace Campbell

Director, Communications

Cavco Industries, Inc.

602.283.9027

About Cavco Industries, Inc.

Cavco Industries, Inc., headquartered in Phoenix, Arizona, designs and produces factory-built housing products primarily distributed through a network of independent and Company-owned retailers. We are one of the largest producers of manufactured and modular homes in the United States, based on reported wholesale shipments. Our products are marketed under a variety of brand names including Cavco, Fleetwood, Palm Harbor, Nationwide, Fairmont, Friendship, Chariot Eagle, Destiny, Commodore, Colony, Pennwest, R-Anell, Manorwood and MidCountry. We are also a leading producer of park model RVs, vacation cabins and factory-built commercial structures. Cavco's finance subsidiary, CountryPlace Mortgage, is an approved Fannie Mae and Freddie Mac seller/servicer and a Ginnie Mae mortgage-backed securities issuer that offers conforming mortgages, non-conforming mortgages and home-only loans to purchasers of factory-built homes. Our insurance subsidiary, Standard Casualty, provides property and casualty insurance to owners of manufactured homes. Additional information about Cavco can be found at .

A photo accompanying this announcement is available at



EN
04/10/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Cavco Industries Inc.

Wedbush Research
  • Wedbush Research
UBI UBISOFT ENTERTAINMENT SA
XNCR XENCOR INC.
XENE XENON PHARMACEUTICALS INC
WDC WESTERN DIGITAL CORPORATION
VYGR VOYAGER THERAPEUTICS INC.
TTWO TAKE-TWO INTERACTIVE SOFTWARE INC.
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
RARE ULTRAGENYX PHARMACEUTICAL INC.
PSTG PURE STORAGE INC. CLASS A
NVDA NVIDIA CORPORATION
NVCR NOVOCURE LTD.
NTAP NETAPP INC.
NBIX NEUROCRINE BIOSCIENCES INC.
MU MICRON TECHNOLOGY INC.
KURA KURA ONCOLOGY INC.
INTC INTEL CORPORATION
HURN HURON CONSULTING GROUP INC.
GME GAMESTOP CORP. CLASS A
GERN GERON CORP.
FATE FATE THERAPEUTICS INC
CTMX CYTOMX THERAPEUTICS INC.
BZH BEAZER HOMES USA INC.
BMRN BIOMARIN PHARMACEUTICAL INC.
BIIB BIOGEN INC.
AXTI AXT INC.
ASND ASCENDIS PHARMA A/S SPONSORED ADR
ARDX ARDELYX INC
CDR CD PROJEKT S.A.
INOD INNODATA
FRX_CN FENNEC PHARMACEUTICALS
7974 NINTENDO CO. LTD.
2330 TAIWAN SEMICONDUCTOR MANUFACTURING CO. LTD.
2303 UNITED MICROELECTRONICS CORP.
EA ELECTRONIC ARTS INC.
CVCO CAVCO INDUSTRIES INC.
ANAB ANAPTYSBIO INC.
ARGX ARGENX ADS
MRSN MERSANA THERAPEUTICS
ROKU ROKU INC. CLASS A
ISR ISORAY
AMZN AMAZON.COM INC.
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
IBM INTERNATIONAL BUSINESS MACHINES CORPORATION
APLS APELLIS PHARMACEUTICALS
DNLI DENALI THERAPEUTICS INC
RCUS ARCUS BIOSCIENCES
SRRK SCHOLAR ROCK HOLDING CORPORATION
KNSA KINIKSA PHARMACEUTICALS
REPL REPLIMUNE GROUP
ARVN ARVINAS HOLDING
YMAB Y-MABS THERAPEUTICS
STRO SUTRO BIOPHARMA
UBER UBER TECHNOLOGIES INC.
STOK STOKE THERAPEUTICS
IGMS IGM BIOSCIENCES
IDYA IDEAYA BIOSCIENCES
PASG PASSAGE BIO
BDTX BLACK DIAMOND THERAPEUTICS
ACET ADICET BIO INC
KROS KEROS THERAPEUTICS
ITOS ITEOS THERAPEUTICS
ZNTL ZENTALIS PHARMACEUTICALS
LRMR LARIMAR THERAPEUTICS INC
PRAX PRAXIS PRECISION MEDICINES
U UNITY SOFTWARE
TVTX TRAVERE THERAPEUTICS INC
PLTR PALANTIR TECHNOLOGIES
VRDN VIRIDIAN THERAPEUTICS INC
IMNM IMMUNOME
PLTK PLAYTIKA HOLDING
RBLX ROBLOX
DAWN DAY ONE BIOPHARMACEUTICALS INC
STX SEAGATE TECHNOLOGY HLDGS PLC
ATXS ASTRIA THERAPEUTICS INC
GFS GLOBALFOUNDRIES INC
GMTX GEMINI THERAPEUTICS INC
VIGL VIGIL NEUROSCIENCE INC
TYRA TYRA BIOSCIENCES INC
EWTX EDGEWISE THERAPEUTICS INC
DDI DOUBLEDOWN INTERACTIVE CO LTD
APGE APOGEE THERAPEUTICS INC
SKLZ SKILLZ INC
EMBRAC B EMBRACER GROUP AB
DNTH DIANTHUS THERAPEUTICS INC
TLX TELIX PHARMACEUTICALS LIMITED
MAZE MAZE THERAPEUTICS INC
 PRESS RELEASE

Cavco Industries Reports Fiscal 2026 First Quarter Results

Cavco Industries Reports Fiscal 2026 First Quarter Results PHOENIX, July 31, 2025 (GLOBE NEWSWIRE) -- Cavco Industries, Inc. (Nasdaq: CVCO) ("we," "our," the "Company" or "Cavco") today announced financial results for the first fiscal quarter ended June 28, 2025. Quarterly Highlights Net revenue was $557 million, up $79 million or 16.6% compared to $478 million in the first quarter of the prior year, primarily on home sales volume growth.Home sales volume was up 14.7% and capacity utilization increased to approximately 75% from approximately 65% in the first quarter of the p...

 PRESS RELEASE

Webcast Alert: Cavco Industries, Inc. Announces Fiscal 2026 First Quar...

Webcast Alert: Cavco Industries, Inc. Announces Fiscal 2026 First Quarter Earnings Release and Conference Call Webcast PHOENIX, July 23, 2025 (GLOBE NEWSWIRE) -- Cavco Industries, Inc. (Nasdaq: CVCO) will release earnings for the first quarter ended June 28, 2025 on Thursday, July 31, 2025 after the close of market. Senior management will discuss the results in a live webcast the following day, Friday, August 1, 2025 at 1:00 p.m. Eastern Time. Date:   August 1, 2025 Time:   1:00 p.m. ET            Listen via Internet: Listen via Telephone: To participate in the call, please register ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch